Skip to main content
Premium Trial:

Request an Annual Quote

A Sentence Comes Down

French doctor Yves Benhamou was sentenced yesterday to time served and three years' supervised release after pleading guilty in an insider-trading case, reports Reuters. Benhamou pleaded guilty to securities fraud, making false statements to the US Federal Bureau of Investigation, and conspiracy for passing secrets about Human Genome Sciences' hepatitis C drug trials to Joseph Skowron, a hedge fund manager at FrontPoint Partners, Bloomberg adds. Benhamou was an advisor on the trial. In addition, he was ordered to pay nearly $6 million in restitution, Reuters adds.

"[Skowron] admitted that after Benhamou passed him the non-public information, FrontPoint sold its stock, avoiding $30 million in losses, according to the US," Boomberg says. Skowron was sentenced in November to five years in prison.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.